Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aminosyn II is a parenteral **amino acid injection** used for short-term nutritional support in patients who cannot adequately receive or absorb enteral nutrition. It is administered intravenously, either by peripheral vein with dilute dextrose and optionally intravenous fat emulsion, or by central vein for total parenteral nutrition support. Its therapeutic effect is nutritional rather than receptor-targeted: it supplies essential and nonessential amino acids as a nitrogen source to maintain or restore protein synthesis, help preserve lean body mass, and prevent or reverse negative nitrogen balance in catabolic or gastrointestinal-compromised patients. The product described is a sulfite-free formulation and is used in clinical settings for nutritional support rather than for a disease-specific pharmacologic mechanism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aminosyn ii.